New, less invasive method for treating mitral regurgitation

Exciting work is being done at the University of Michigan Frankel Cardiovascular Center’s Mitral Valve Clinic where doctors are involved in testing a new, less invasive method for treating mitral regurgitation. An internationally known leader in mitral valve surgery and one of the largest mitral valve clinics in the country, U-M has begun screening patients for the COAPT Trial. The U.S. trial will study an

Dr. Steven Bolling

Dr. Steven Bolling

investigational device known as the mitral clip in patients who have functional mitral regurgitation and are considered extremely high-risk for mitral valve surgery.

According to Steven F. Bolling, professor of cardiac surgery and director of the U-M Mitral Valve Clinic, the mitral clip device is designed to prevent the mitral valve from leaking in patients with mitral regurgitation.

“The clip is less invasive than traditional surgery. For those who do not tolerate surgery well — in particular the elderly, the very ill and those with extensive heart disease — the mitral clip may be a good option.” The COAPT Trial, says Bolling, could prove the mitral clip to be a viable treatment for mitral regurgitation versus traditional treatment methods that are not always favorable for certain patients.

The COAPT Trial will study two groups of patients: one assigned to a “mitral clip group” and one a “control group.” Both will receive the current recommended treatment, also known as the standard of care.

For patients with mitral regurgitation who are considered extremely high-risk for mitral valve surgery, the standard of care may include one or more of these therapies:

Dr. Steven Bolling meets with a patient.

Dr. Steven Bolling meets with a patient.

  • Medications
  • Implantation of a pacemaker, a device that delivers electrical impulses to help the heart beat normally
  • Treatments for coronary artery disease

The COAPT Trial reflects the trend toward less invasive options for high-risk patients in need of treatment for heart valve issues. For example, the transcatheter aortic valve replacement, also known as TAVR, is a minimally invasive procedure to replace the aortic valve. This alternative to surgery is giving hope to high-risk aortic patients at U-M.

The mitral clip clinic meets each Thursday at 10:00 a.m. at the U-M Frankel Cardiovascular Center.

Take the next step:

  • Ask your physician if you think the COAPT Trial might be right for you.
  • Learn more about clinical trial call 1-888-286-4420, or email CVCVolunteer@med.umich.edu.

Frankel-informal-vertical-sigThe University of Michigan Samuel and Jean Frankel Cardiovascular Center is the top-ranked heart and heart surgery program among Michigan hospitals. To learn more, visit our website at umcvc.org.